Viskase Holdings, Inc.
ENZNOTCHealthcare · Biological Products, (No Diagnostic Substances) · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | — | $26,000 | — | $26,000 | $701,000 | $52,000 |
| Operating income | −$5.3M | −$1.3M | −$1.0M | −$1.0M | −$469,000 | −$1.3M |
| Net income | −$3.4M | $778,000 | $1.4M | −$186,000 | −$469,000 | −$1.3M |
| Total assets | $42.8M | $47.2M | $47.7M | $47.6M | $47.8M | $48.2M |
| Total liabilities | — | — | — | — | — | — |
| Equity | −$2.5M | $3.0M | $3.5M | $3.4M | $4.9M | $7.4M |
| EPS (diluted) | $-0.07 | $-0.01 | $0.00 | $-0.02 | $-0.03 | $-0.03 |
| Shares out. | 74.2M | 74.2M | 74.2M | 74.2M | 74.2M | 44.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- —
- Return on equity
- 135.0%
- Return on assets
- −8.0%
- Return on capital (ROCE)
- −12.6%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $-0.03
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- −538.2%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Accruals / assets
- −0.9%clean
- Piotroski F-Score
- 3/6weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 1 warning● 2 good- Negative shareholder equity
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Negative operating cash flow
- Strong return on equity (>15%)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Sep 13, 2005
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Icahn Carl C10% owner | Mar 25, 2026 | D | 39,277 | — |
| Read Randolph CDirector | Jun 14, 2023 | Buy | 15,000 | $0.13 |
| Couchman Jonathan10% owner | Aug 13, 2021 | Sell | 50,000 | $0.39 |
| Read Randolph CDirector | Nov 16, 2020 | Buy | 50,450 | $0.15 |
| Bleznick JordanDirector | Nov 13, 2020 | Buy | 100,000 | $0.15 |
| Icahn Carl C10% owner | Oct 9, 2020 | Option exercise | 29.5M | — |
| Couchman Jonathan10% owner | Aug 24, 2020 | Sell | 52,100 | $0.18 |
| Couchman Jonathan10% owner | Aug 5, 2020 | Buy | 506,292 | $0.20 |
| Couchman Jonathan10% owner | Mar 13, 2020 | Buy | 19,709 | $0.14 |
| Couchman Jonathan10% owner | Feb 11, 2019 | Buy | 15,500 | $0.25 |
| Couchman Jonathan10% owner | Aug 15, 2018 | Buy | 20,600 | $0.26 |
| Couchman Jonathan10% owner | Apr 13, 2018 | Buy | 4,700 | $0.26 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 9 | 1.0 | -97.0% |
| Apr 30, 2026 | 300 | 1.0 | +20.5% |
| Mar 13, 2026 | 96 | 1.0 | +4.3% |
| Feb 27, 2026 | 92 | 1.0 | 0.0% |
| Feb 13, 2026 | 92 | 1.0 | -98.2% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Modified shareholder rights · Amended charter or bylaws · Regulation FD disclosureMay 5, 2026
- Director / officer changeMay 1, 2026
- Entered a material agreement · New financial obligationApr 21, 2026
- Changed auditorApr 16, 2026
- Director / officer changeApr 15, 2026
- Completed an acquisition or disposition · Unregistered equity sale · Change in control · Director / officer change · Amended charter or bylaws · Regulation FD disclosureMar 26, 2026
- Regulation FD disclosureMar 25, 2026
- Entered a material agreement · Modified shareholder rights · Amended charter or bylaws · Regulation FD disclosureMar 24, 2026
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 8-A12GMay 5, 2026
- 8-KFORM 8-KMay 5, 2026
- 10-QMay 4, 2026
- 3OWNERSHIP DOCUMENTMay 1, 2026
- 8-K/AFORM 8-K/AMay 1, 2026
- 8-KFORM 8-KMay 1, 2026
- 10-K/AApr 29, 2026
- 8-KFORM 8-KApr 21, 2026
- 8-KFORM 8-KApr 16, 2026
- 8-KFORM 8-KApr 15, 2026
- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESMar 27, 2026
- SCHEDULE 13D/AMar 27, 2026
- 3OWNERSHIP DOCUMENTMar 26, 2026
- 3OWNERSHIP DOCUMENTMar 26, 2026
- 3OWNERSHIP DOCUMENTMar 26, 2026
Corporate family
Spin-offs from Viskase Holdings, Inc. (1)
- Evivrus, Inc.withdrawnNov 24, 2008details
From the spin-off filings we track. Follow a company to walk its own history.
Event-driven situations (3)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.